 EATONTOWN, NJ ACCESSWIRE May 6, 2021 American CryoStem Corporation OTC PINK:CRYO a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and therapies announced today, that it has signed a Letter of Intent LOI with Advanced Regenerative Associates, LLC ARA of Tinton Falls, NJ for the development of a cell-based wound covering treatment for non-healing wounds, skin ulcers, and limb ischemia associated with type II diabetes, burns, and other systemic conditions. Advanced Regenerative Associates, led by Dr. Michael J. 